Matches in Nanopublications for { ?s ?p "The recent announcement that RECOVERY , a randomised controlled trial comparing dexamethasone to placebo in COVID-19 , was terminated early due to excess deaths in the control group further" ?g. }
Showing items 1 to 84 of
84
with 100 items per page.
- SUBJECT label "The recent announcement that RECOVERY , a randomised controlled trial comparing dexamethasone to placebo in COVID-19 , was terminated early due to excess deaths in the control group further" provenance.
- SUBJECT label "The recent announcement that RECOVERY , a randomised controlled trial comparing dexamethasone to placebo in COVID-19 , was terminated early due to excess deaths in the control group further" provenance.
- SUBJECT label "The recent announcement that RECOVERY , a randomised controlled trial comparing dexamethasone to placebo in COVID-19 , was terminated early due to excess deaths in the control group further" provenance.
- SUBJECT label "The recent announcement that RECOVERY , a randomised controlled trial comparing dexamethasone to placebo in COVID-19 , was terminated early due to excess deaths in the control group further" provenance.
- SUBJECT label "The recent announcement that RECOVERY , a randomised controlled trial comparing dexamethasone to placebo in COVID-19 , was terminated early due to excess deaths in the control group further" provenance.
- SUBJECT label "The recent announcement that RECOVERY , a randomised controlled trial comparing dexamethasone to placebo in COVID-19 , was terminated early due to excess deaths in the control group further" provenance.
- SUBJECT label "The recent announcement that RECOVERY , a randomised controlled trial comparing dexamethasone to placebo in COVID-19 , was terminated early due to excess deaths in the control group further" provenance.
- SUBJECT label "The recent announcement that RECOVERY , a randomised controlled trial comparing dexamethasone to placebo in COVID-19 , was terminated early due to excess deaths in the control group further" provenance.
- SUBJECT label "The recent announcement that RECOVERY , a randomised controlled trial comparing dexamethasone to placebo in COVID-19 , was terminated early due to excess deaths in the control group further" provenance.
- SUBJECT label "The recent announcement that RECOVERY , a randomised controlled trial comparing dexamethasone to placebo in COVID-19 , was terminated early due to excess deaths in the control group further" provenance.
- SUBJECT label "The recent announcement that RECOVERY , a randomised controlled trial comparing dexamethasone to placebo in COVID-19 , was terminated early due to excess deaths in the control group further" provenance.
- SUBJECT label "The recent announcement that RECOVERY , a randomised controlled trial comparing dexamethasone to placebo in COVID-19 , was terminated early due to excess deaths in the control group further" provenance.
- SUBJECT label "The recent announcement that RECOVERY , a randomised controlled trial comparing dexamethasone to placebo in COVID-19 , was terminated early due to excess deaths in the control group further" provenance.
- SUBJECT label "The recent announcement that RECOVERY , a randomised controlled trial comparing dexamethasone to placebo in COVID-19 , was terminated early due to excess deaths in the control group further" provenance.
- SUBJECT label "The recent announcement that RECOVERY , a randomised controlled trial comparing dexamethasone to placebo in COVID-19 , was terminated early due to excess deaths in the control group further" provenance.
- SUBJECT label "The recent announcement that RECOVERY , a randomised controlled trial comparing dexamethasone to placebo in COVID-19 , was terminated early due to excess deaths in the control group further" provenance.
- SUBJECT label "The recent announcement that RECOVERY , a randomised controlled trial comparing dexamethasone to placebo in COVID-19 , was terminated early due to excess deaths in the control group further" provenance.
- SUBJECT label "The recent announcement that RECOVERY , a randomised controlled trial comparing dexamethasone to placebo in COVID-19 , was terminated early due to excess deaths in the control group further" provenance.
- SUBJECT label "The recent announcement that RECOVERY , a randomised controlled trial comparing dexamethasone to placebo in COVID-19 , was terminated early due to excess deaths in the control group further" provenance.
- SUBJECT label "The recent announcement that RECOVERY , a randomised controlled trial comparing dexamethasone to placebo in COVID-19 , was terminated early due to excess deaths in the control group further" provenance.
- SUBJECT label "The recent announcement that RECOVERY , a randomised controlled trial comparing dexamethasone to placebo in COVID-19 , was terminated early due to excess deaths in the control group further" provenance.
- SUBJECT label "The recent announcement that RECOVERY , a randomised controlled trial comparing dexamethasone to placebo in COVID-19 , was terminated early due to excess deaths in the control group further" provenance.
- SUBJECT label "The recent announcement that RECOVERY , a randomised controlled trial comparing dexamethasone to placebo in COVID-19 , was terminated early due to excess deaths in the control group further" provenance.
- SUBJECT label "The recent announcement that RECOVERY , a randomised controlled trial comparing dexamethasone to placebo in COVID-19 , was terminated early due to excess deaths in the control group further" provenance.
- SUBJECT label "The recent announcement that RECOVERY , a randomised controlled trial comparing dexamethasone to placebo in COVID-19 , was terminated early due to excess deaths in the control group further" provenance.
- SUBJECT label "The recent announcement that RECOVERY , a randomised controlled trial comparing dexamethasone to placebo in COVID-19 , was terminated early due to excess deaths in the control group further" provenance.
- SUBJECT label "The recent announcement that RECOVERY , a randomised controlled trial comparing dexamethasone to placebo in COVID-19 , was terminated early due to excess deaths in the control group further" provenance.
- SUBJECT label "The recent announcement that RECOVERY , a randomised controlled trial comparing dexamethasone to placebo in COVID-19 , was terminated early due to excess deaths in the control group further" provenance.
- SUBJECT label "The recent announcement that RECOVERY , a randomised controlled trial comparing dexamethasone to placebo in COVID-19 , was terminated early due to excess deaths in the control group further" provenance.
- SUBJECT label "The recent announcement that RECOVERY , a randomised controlled trial comparing dexamethasone to placebo in COVID-19 , was terminated early due to excess deaths in the control group further" provenance.
- SUBJECT label "The recent announcement that RECOVERY , a randomised controlled trial comparing dexamethasone to placebo in COVID-19 , was terminated early due to excess deaths in the control group further" provenance.
- SUBJECT label "The recent announcement that RECOVERY , a randomised controlled trial comparing dexamethasone to placebo in COVID-19 , was terminated early due to excess deaths in the control group further" provenance.
- SUBJECT label "The recent announcement that RECOVERY , a randomised controlled trial comparing dexamethasone to placebo in COVID-19 , was terminated early due to excess deaths in the control group further" provenance.
- SUBJECT label "The recent announcement that RECOVERY , a randomised controlled trial comparing dexamethasone to placebo in COVID-19 , was terminated early due to excess deaths in the control group further" provenance.
- SUBJECT label "The recent announcement that RECOVERY , a randomised controlled trial comparing dexamethasone to placebo in COVID-19 , was terminated early due to excess deaths in the control group further" provenance.
- SUBJECT label "The recent announcement that RECOVERY , a randomised controlled trial comparing dexamethasone to placebo in COVID-19 , was terminated early due to excess deaths in the control group further" provenance.
- SUBJECT label "The recent announcement that RECOVERY , a randomised controlled trial comparing dexamethasone to placebo in COVID-19 , was terminated early due to excess deaths in the control group further" provenance.
- SUBJECT label "The recent announcement that RECOVERY , a randomised controlled trial comparing dexamethasone to placebo in COVID-19 , was terminated early due to excess deaths in the control group further" provenance.
- SUBJECT label "The recent announcement that RECOVERY , a randomised controlled trial comparing dexamethasone to placebo in COVID-19 , was terminated early due to excess deaths in the control group further" provenance.
- SUBJECT label "The recent announcement that RECOVERY , a randomised controlled trial comparing dexamethasone to placebo in COVID-19 , was terminated early due to excess deaths in the control group further" provenance.
- SUBJECT label "The recent announcement that RECOVERY , a randomised controlled trial comparing dexamethasone to placebo in COVID-19 , was terminated early due to excess deaths in the control group further" provenance.
- SUBJECT label "The recent announcement that RECOVERY , a randomised controlled trial comparing dexamethasone to placebo in COVID-19 , was terminated early due to excess deaths in the control group further" provenance.
- SUBJECT label "The recent announcement that RECOVERY , a randomised controlled trial comparing dexamethasone to placebo in COVID-19 , was terminated early due to excess deaths in the control group further" provenance.
- SUBJECT label "The recent announcement that RECOVERY , a randomised controlled trial comparing dexamethasone to placebo in COVID-19 , was terminated early due to excess deaths in the control group further" provenance.
- SUBJECT label "The recent announcement that RECOVERY , a randomised controlled trial comparing dexamethasone to placebo in COVID-19 , was terminated early due to excess deaths in the control group further" provenance.
- SUBJECT label "The recent announcement that RECOVERY , a randomised controlled trial comparing dexamethasone to placebo in COVID-19 , was terminated early due to excess deaths in the control group further" provenance.
- SUBJECT label "The recent announcement that RECOVERY , a randomised controlled trial comparing dexamethasone to placebo in COVID-19 , was terminated early due to excess deaths in the control group further" provenance.
- SUBJECT label "The recent announcement that RECOVERY , a randomised controlled trial comparing dexamethasone to placebo in COVID-19 , was terminated early due to excess deaths in the control group further" provenance.
- SUBJECT label "The recent announcement that RECOVERY , a randomised controlled trial comparing dexamethasone to placebo in COVID-19 , was terminated early due to excess deaths in the control group further" provenance.
- SUBJECT label "The recent announcement that RECOVERY , a randomised controlled trial comparing dexamethasone to placebo in COVID-19 , was terminated early due to excess deaths in the control group further" provenance.
- SUBJECT label "The recent announcement that RECOVERY , a randomised controlled trial comparing dexamethasone to placebo in COVID-19 , was terminated early due to excess deaths in the control group further" provenance.
- SUBJECT label "The recent announcement that RECOVERY , a randomised controlled trial comparing dexamethasone to placebo in COVID-19 , was terminated early due to excess deaths in the control group further" provenance.
- SUBJECT label "The recent announcement that RECOVERY , a randomised controlled trial comparing dexamethasone to placebo in COVID-19 , was terminated early due to excess deaths in the control group further" provenance.
- SUBJECT label "The recent announcement that RECOVERY , a randomised controlled trial comparing dexamethasone to placebo in COVID-19 , was terminated early due to excess deaths in the control group further" provenance.
- SUBJECT label "The recent announcement that RECOVERY , a randomised controlled trial comparing dexamethasone to placebo in COVID-19 , was terminated early due to excess deaths in the control group further" provenance.
- SUBJECT label "The recent announcement that RECOVERY , a randomised controlled trial comparing dexamethasone to placebo in COVID-19 , was terminated early due to excess deaths in the control group further" provenance.
- SUBJECT label "The recent announcement that RECOVERY , a randomised controlled trial comparing dexamethasone to placebo in COVID-19 , was terminated early due to excess deaths in the control group further" provenance.
- SUBJECT label "The recent announcement that RECOVERY , a randomised controlled trial comparing dexamethasone to placebo in COVID-19 , was terminated early due to excess deaths in the control group further" provenance.
- SUBJECT label "The recent announcement that RECOVERY , a randomised controlled trial comparing dexamethasone to placebo in COVID-19 , was terminated early due to excess deaths in the control group further" provenance.
- SUBJECT label "The recent announcement that RECOVERY , a randomised controlled trial comparing dexamethasone to placebo in COVID-19 , was terminated early due to excess deaths in the control group further" provenance.
- SUBJECT label "The recent announcement that RECOVERY , a randomised controlled trial comparing dexamethasone to placebo in COVID-19 , was terminated early due to excess deaths in the control group further" provenance.
- SUBJECT label "The recent announcement that RECOVERY , a randomised controlled trial comparing dexamethasone to placebo in COVID-19 , was terminated early due to excess deaths in the control group further" provenance.
- SUBJECT label "The recent announcement that RECOVERY , a randomised controlled trial comparing dexamethasone to placebo in COVID-19 , was terminated early due to excess deaths in the control group further" provenance.
- SUBJECT label "The recent announcement that RECOVERY , a randomised controlled trial comparing dexamethasone to placebo in COVID-19 , was terminated early due to excess deaths in the control group further" provenance.
- SUBJECT label "The recent announcement that RECOVERY , a randomised controlled trial comparing dexamethasone to placebo in COVID-19 , was terminated early due to excess deaths in the control group further" provenance.
- SUBJECT label "The recent announcement that RECOVERY , a randomised controlled trial comparing dexamethasone to placebo in COVID-19 , was terminated early due to excess deaths in the control group further" provenance.
- SUBJECT label "The recent announcement that RECOVERY , a randomised controlled trial comparing dexamethasone to placebo in COVID-19 , was terminated early due to excess deaths in the control group further" provenance.
- SUBJECT label "The recent announcement that RECOVERY , a randomised controlled trial comparing dexamethasone to placebo in COVID-19 , was terminated early due to excess deaths in the control group further" provenance.
- SUBJECT label "The recent announcement that RECOVERY , a randomised controlled trial comparing dexamethasone to placebo in COVID-19 , was terminated early due to excess deaths in the control group further" provenance.
- SUBJECT label "The recent announcement that RECOVERY , a randomised controlled trial comparing dexamethasone to placebo in COVID-19 , was terminated early due to excess deaths in the control group further" provenance.
- SUBJECT label "The recent announcement that RECOVERY , a randomised controlled trial comparing dexamethasone to placebo in COVID-19 , was terminated early due to excess deaths in the control group further" provenance.
- SUBJECT label "The recent announcement that RECOVERY , a randomised controlled trial comparing dexamethasone to placebo in COVID-19 , was terminated early due to excess deaths in the control group further" provenance.
- SUBJECT label "The recent announcement that RECOVERY , a randomised controlled trial comparing dexamethasone to placebo in COVID-19 , was terminated early due to excess deaths in the control group further" provenance.
- SUBJECT label "The recent announcement that RECOVERY , a randomised controlled trial comparing dexamethasone to placebo in COVID-19 , was terminated early due to excess deaths in the control group further" provenance.
- SUBJECT label "The recent announcement that RECOVERY , a randomised controlled trial comparing dexamethasone to placebo in COVID-19 , was terminated early due to excess deaths in the control group further" provenance.
- SUBJECT label "The recent announcement that RECOVERY , a randomised controlled trial comparing dexamethasone to placebo in COVID-19 , was terminated early due to excess deaths in the control group further" provenance.
- SUBJECT label "The recent announcement that RECOVERY , a randomised controlled trial comparing dexamethasone to placebo in COVID-19 , was terminated early due to excess deaths in the control group further" provenance.
- SUBJECT label "The recent announcement that RECOVERY , a randomised controlled trial comparing dexamethasone to placebo in COVID-19 , was terminated early due to excess deaths in the control group further" provenance.
- SUBJECT label "The recent announcement that RECOVERY , a randomised controlled trial comparing dexamethasone to placebo in COVID-19 , was terminated early due to excess deaths in the control group further" provenance.
- SUBJECT label "The recent announcement that RECOVERY , a randomised controlled trial comparing dexamethasone to placebo in COVID-19 , was terminated early due to excess deaths in the control group further" provenance.
- SUBJECT label "The recent announcement that RECOVERY , a randomised controlled trial comparing dexamethasone to placebo in COVID-19 , was terminated early due to excess deaths in the control group further" provenance.
- SUBJECT label "The recent announcement that RECOVERY , a randomised controlled trial comparing dexamethasone to placebo in COVID-19 , was terminated early due to excess deaths in the control group further" provenance.
- SUBJECT label "The recent announcement that RECOVERY , a randomised controlled trial comparing dexamethasone to placebo in COVID-19 , was terminated early due to excess deaths in the control group further" provenance.
- SUBJECT label "The recent announcement that RECOVERY , a randomised controlled trial comparing dexamethasone to placebo in COVID-19 , was terminated early due to excess deaths in the control group further" provenance.